GH
Research Snapshot
Static fundamentals, valuation context, and investor signals for GUARDANT HEALTH, INC. (GH).
DCF ready
Valuation
N/A
EV/FCF, N/A FCF yield
Quality
-29.6%
ROIC, -23.7% FCF margin
Growth
27.9%
5Y sales (revenue) CAGR
Balance sheet
-15.1x
Debt/equity, 4.8x current ratio
Superinvestors
1
Top: Polen Capital Management (0.0%)
Strengths to research
- Revenue compounded at 27.9% over five years.
- Return on equity is strong at 419.2%.
- Debt/equity looks manageable at -15.1x.
- 10 annual periods are available for trend analysis.
Watchouts
- Free cash flow margin is negative at -23.7%.
- Valuation multiples are limited or unavailable.
Annual data: 10 periods
Quarterly data: 24 periods
Stock snapshot: May 25, 2026
Static dataset: May 25, 2026
Quality Scorecard
Build-time composite score for GH.
Grade F
21
/ 100
Financial Charts
No financial data available for GH (annual).
1 superinvestors own GH
Current quarter ownership and quarter-over-quarter share changes.
Superinvestor ownership
| Fund | Shares | Value | % Portfolio | QoQ Change |
|---|---|---|---|---|
| Polen Capital Management Polen Capital Management | 34,725 | $3M | 0.02% | 0.0% |